Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Biosimilar Cost-Savings Needed To Balance Extrapolation Risk, Advisors Tell FDA

Executive Summary

Inflectra should be priced considerably lower than Remicade given that approval for some indications would be based on extrapolation, advisory committee members said; Celltrion exec suggests price could approximate the 30% discount seen in Europe.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register